共 8 条
[2]
Activation of 5-hydroxytryptamine<sub>1B/1D/1F</sub> receptors as a mechanism of action of antimigraine drugs.[J].Martha B Ramírez Rosas;Sieneke Labruijere;Carlos M Villalón;Antoinette Maassen VanDenBrink.Expert Opinion on Pharmacotherapy.2013, 12
[3]
Two Mechanisms Involved in Trigeminal CGRP Release: Implications for Migraine Treatment.[J].Paul L. Durham;Caleb G. Masterson.Headache: The Journal of Head and Face Pain.2012, 1
[6]
[7]
mRNA expression of 5-hydroxytryptamine 1B; 1D; and 1F receptors and their role in controlling the release of calcitonin gene–related peptide in the rat trigeminovascular system.[J].Dipak V. Amrutkar;Kenneth B. Ploug;Anders Hay-Schmidt;Frank Porreca;Jes Olesen;Inger Jansen-Olesen.Pain.2012, 4
[8]
Distribution of 5-HT 1B ; 5-HT 1D and 5-HT 1F receptor expression in rat trigeminal and dorsal root ganglia neurons: Relevance to the selective anti-migraine effect of triptans.[J].J.D. Classey;T. Bartsch;P.J. Goadsby.Brain Research.2010,

